Stentys SA

Type: Company
Name: Stentys SA
Nationality: United States
Fact Sheet: Fact Sheet for Stentys
First reported 19 hours ago - Updated 19 hours ago - 1 reports

Brilinta Prehospital: No Reperfusion Boost, Less Thrombosis

BARCELONA, SPAIN — Giving ticagrelor (Brilinta, AstraZeneca) to STEMI patients in the ambulance en route to a PCI-capable hospital does not improve coronary reperfusion preprocedure, but it may reduce the early risk of stent thrombosis, investigators ... [Published American Journal of Public Health - 19 hours ago]
Entities: Thrombosis, Stent, Brilinta
First reported Sep 01 2014 - Updated Sep 01 2014 - 1 reports

Prehospital Ticagrelor in ST-Segment Elevation Myocardial Infarction

Effective antiplatelet therapy combining the inhibition of both thromboxane A 2 –dependent platelet aggregation and P2Y 12 receptors is necessary in patients undergoing percutaneous coronary intervention (PCI), particularly those with ST-segment elevation ... [Published New England Journal of Medicine - Sep 01 2014]
First reported Aug 25 2014 - Updated Aug 26 2014 - 1 reports

STENTYS to Report First-Half Results on September 22, 2014

--Regulatory News:STENTYS (Paris:STNT) (FR0010949404 -- STNT), a medical technology company commercializing, in Europe, the world's first and only Self-Apposing(R) stent to treat acute myocardial infarction (AMI), today announces it will report financial ... [Published Scottrade - Aug 25 2014]
First reported Aug 05 2014 - Updated Aug 05 2014 - 1 reports

Stentys ditches bare metal stents as customers move to drug-eluting versions

Stentys announced that it is discontinuing enrollment in its Apposition V trial for its bare metal stent and focusing its resources and money on its next-generation sirolimus-eluting stent featuring a new delivery catheter.The company said it made the ... [Published Fierce Drug Delivery - Aug 05 2014]
First reported Jul 24 2014 - Updated Jul 24 2014 - 1 reports

STENTYS First Half 2014 Revenues Rise 18%

PRINCETON, N.J. & PARIS--(BUSINESS WIRE)--STENTYS First Half 2014 Revenues Rise 18% ... [Published Business Wire Health News - Jul 24 2014]
Entities: Stentys SA, Paris
First reported Jul 09 2014 - Updated Jul 10 2014 - 1 reports

STENTYS Expands Marketing of the Self-Apposing Stent in South America

PRINCETON, N.J. & PARIS--(BUSINESS WIRE)--STENTYS has entered the Latin American coronary stent market, signing agreements to market its Self-Apposing Stent in Argentina, Chile and Colombia. ... [Published Business Wire Health News - Jul 09 2014]
First reported Jun 12 2014 - Updated Jun 13 2014 - 1 reports

STENTYS Completes the Acquisition of Cappella Peel Away Inc.

PRINCETON, N.J. & PARIS--(BUSINESS WIRE)--STENTYS has completed its acquisition of Cappella Peel Away Inc. for a total of 1 million Euros in stock and cash. ... [Published Business Wire Health News - Jun 12 2014]
First reported Jun 04 2014 - Updated Jun 05 2014 - 1 reports

STENTYS to Acquire Stent Delivery Technology for Its Next-Generation of Self-Apposing Stents

PRINCETON, N.J. & PARIS--(BUSINESS WIRE)--STENTYS will acquire a catheter technology for a next-generation delivery system for its Self-Apposing Stent; it has been validated by an extensive number of Cappella Sideguard stent implants. ... [Published Business Wire Health News - Jun 04 2014]
First reported May 27 2014 - Updated May 27 2014 - 1 reports

STENTYS Self-Apposing Stent Featured Prominently at 2014 EuroPCR Conference

PRINCETON, N.J. & PARIS--(BUSINESS WIRE)--STENTYS reported multiple sessions, symposia and case presentations featuring STENTYS Self-Apposing stents during EuroPCR 2014. ... [Published Business Wire Health News - May 27 2014]
Entities: Stentys SA, Stent, Paris
First reported May 20 2014 - Updated May 21 2014 - 1 reports

STENTYS Sirolimus-Eluting Stent Demonstrates Best in Class Efficacy for Heart Attack Patients

PRINCETON, N.J. & PARIS--(BUSINESS WIRE)--STENTYS today presented final results from the APPOSITION IV study of its new Self-Apposing sirolimus-eluting stent (SES) during the Hotline session at the EuroPCR conference in Paris. ... [Published Business Wire Health News - May 20 2014]
First reported May 14 2014 - Updated May 14 2014 - 1 reports

STENTYS Secures a Standby Equity Facility

PRINCETON, N.J. & PARIS--(BUSINESS WIRE)--STENTYS today announced that it has entered into a Standby Equity Facility with Société Générale, exercisable by tranches at STENTYS’ discretion. ... [Published Business Wire Health News - May 14 2014]
First reported Apr 29 2014 - Updated Apr 29 2014 - 3 reports

STENTYS’ Self-Apposing Stent Featured in New Article Published by the Journal of the American College of Cardiology

PRINCETON, N.J. & PARIS--(BUSINESS WIRE)--STENTYS' Self-Apposing Stent has been highlighted as a solution to minimize stent malapposition in a new article published by the Journal of the American College of Cardiology. ... [Published Business Wire Science: Science News - Apr 29 2014]

Quotes

"Prehospital ticagrelor administration a short time before PCI in patients with ongoing STEMI is safe but does not improve pre-PCI coronary reperfusion. It"
"This decision to terminate enrollment in the study was made in close collaboration with the study's Steering Committee. We are affirming our plan to invest the Company's financial resources where we can make the greatest positive impact on a patient's health in the future and be best positioned to take a leading share of this dynamic market" said CEO and co-founder Gonzague Issenmann in a statement

More Content

All (19) | News (4) | Reports (0) | Blogs (14) | Audio/Video (0) | Fact Sheets (1) | Press Releases (0)
sort by: Date | Relevance
Brilinta Prehospital: No Reperfusion Boost, Les... [Published American Journal of Public Health - 19 hours ago]
Prehospital Ticagrelor in ST-Segment Elevation ... [Published New England Journal of Medicine - Sep 01 2014]
STENTYS to Report First-Half Results on Septemb... [Published Scottrade - Aug 25 2014]
Stentys ditches bare metal stents as customers ... [Published Fierce Drug Delivery - Aug 05 2014]
STENTYS First Half 2014 Revenues Rise 18% [Published Business Wire Health News - Jul 24 2014]
STENTYS Expands Marketing of the Self-Apposing ... [Published Business Wire Health News - Jul 09 2014]
STENTYS Completes the Acquisition of Cappella P... [Published Business Wire Health News - Jun 12 2014]
STENTYS to Acquire Stent Delivery Technology fo... [Published Business Wire Health News - Jun 04 2014]
STENTYS Self-Apposing Stent Featured Prominentl... [Published Business Wire Health News - May 27 2014]
STENTYS Sirolimus-Eluting Stent Demonstrates Be... [Published Business Wire Health News - May 20 2014]
STENTYS Secures a Standby Equity Facility [Published Business Wire Health News - May 14 2014]
STENTYS: Journal of the American College of Car... [Published Business Wire Health News - May 06 2014]
STENTYS’ Self-Apposing Stent Featured in New Ar... [Published Business Wire Science: Science News - Apr 29 2014]
STENTYS’ Self-Apposing Stent Featured in New Ar... [Published EON Science - Apr 29 2014]
STENTYS’ Self-Apposing Stent Featured in New Ar... [Published Business Wire Health News - Apr 29 2014]
STENTYS: First Quarter Revenues Up 18% from 2013 [Published Business Wire Health News - Apr 24 2014]
STENTYS Appoints Medical Device Executive to it... [Published Business Wire Health News - Apr 10 2014]
STENTYS Reports 2013 Financial Results [Published Business Wire Health News - Mar 13 2014]
Fact Sheet for Stentys [Published Silobreaker - Sep 03 2010]
1
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
STENTYS First Half 2014 Revenues Rise 18% [Published Business Wire Health News - Jul 24 2014]
PRINCETON, N.J. & PARIS--(BUSINESS WIRE)--STENTYS First Half 2014 Revenues Rise 18% ...
STENTYS Expands Marketing of the Self-Apposing ... [Published Business Wire Health News - Jul 09 2014]
PRINCETON, N.J. & PARIS--(BUSINESS WIRE)--STENTYS has entered the Latin American coronary stent market, signing agreements to market its Self-Apposing Stent in Argentina, Chile and Colombia. ...
STENTYS Completes the Acquisition of Cappella P... [Published Business Wire Health News - Jun 12 2014]
PRINCETON, N.J. & PARIS--(BUSINESS WIRE)--STENTYS has completed its acquisition of Cappella Peel Away Inc. for a total of 1 million Euros in stock and cash. ...
STENTYS to Acquire Stent Delivery Technology fo... [Published Business Wire Health News - Jun 04 2014]
PRINCETON, N.J. & PARIS--(BUSINESS WIRE)--STENTYS will acquire a catheter technology for a next-generation delivery system for its Self-Apposing Stent; it has been validated by an extensive number of Cappella Sideguard stent implants. ...
STENTYS Self-Apposing Stent Featured Prominentl... [Published Business Wire Health News - May 27 2014]
PRINCETON, N.J. & PARIS--(BUSINESS WIRE)--STENTYS reported multiple sessions, symposia and case presentations featuring STENTYS Self-Apposing stents during EuroPCR 2014. ...
1 2 3
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.